Bionano Genomics Inc (BNGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 6,073 | 7,771 | 8,769 | 10,721 | 9,318 |
| Cost of Goods | 14,519 | 5,186 | 5,945 | 8,282 | 6,569 |
| Gross Profit | -8,446 | 2,585 | 2,824 | 2,439 | 2,749 |
| Operating Expenses | 35,974 | 19,789 | 34,892 | 27,673 | 116,530 |
| Operating Income | -43,901 | -17,018 | -31,123 | -24,952 | -113,212 |
| Other Income | -321 | 820 | -317 | -18,975 | 685 |
| Pre-tax Income | -44,222 | -16,198 | -31,440 | -43,927 | -112,527 |
| Income Tax | 24 | 26 | -18 | -36 | 39 |
| Net Income Continuous | -44,246 | -16,224 | -31,422 | -43,891 | -112,566 |
| Net Income | $-44,246 | $-16,224 | $-31,422 | $-43,891 | $-112,566 |
| EPS Basic Total Ops | -30.92 | -14.41 | -35.75 | -67.88 | -192.81 |
| EPS Basic Continuous Ops | -30.92 | -14.41 | -35.75 | -68.45 | -192.58 |
| EPS Diluted Total Ops | -30.92 | -14.41 | -35.75 | -67.88 | -192.81 |
| EPS Diluted Continuous Ops | -30.92 | -14.41 | -35.75 | -68.45 | -192.58 |
| EPS Diluted Before Non-Recurring Items | -19.16 | -14.37 | -35.93 | -57.49 | N/A |
| EBITDA(a) | $-18,534 | $-14,645 | $-28,311 | $-21,535 | $-32,339 |